Clinical Trials Directory

Trials / Completed

CompletedNCT01509157

MDRS for Prevention of Nocturnal Hypoglycemia

Prevention of Nocturnal Hypoglycemia in Children and Young Adults With Type 1 Diabetes Using a Remote Safety and Control Diabetes Management System

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Rabin Medical Center · Academic / Other
Sex
All
Age
4 Years – 24 Years
Healthy volunteers
Not accepted

Summary

The investigators have developed a unique Remote \& Safety diabetes management system (MDRS) that offers real-time remote monitoring and control of glucose levels. The system allows the supervising personal to alarm the patient and intervene in cases such as pending hypoglycemia, long standing hyperglycemia or technical faults.The aim of this feasibility study is to evaluate the efficacy of the MDRS system in preventing nocturnal hypoglycemia in children and young adults with type 1 diabetes.

Conditions

Interventions

TypeNameDescription
DEVICEMDRS System (Remote & Safety diabetes management system)Participants will be using the MDRS system combined with their regular Continuous Glucose Monitoring during nightime for 2 weeks. The MDRS will allow the supervising personal to get real time remote data of glucose level and to alarm the patients and intervene in cases such as pending hypoglycemia, long standing hyperglycemia or technical faults
PROCEDUREContinuous Glucose MonitoringParticipants will be using their regular Continuous Glucose Monitoring during nightime for 2 weeks, without using the MDRS remote control system

Timeline

Start date
2012-01-01
Primary completion
2013-02-01
Completion
2013-04-01
First posted
2012-01-12
Last updated
2013-07-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01509157. Inclusion in this directory is not an endorsement.